Tyrosinemia
Billable / specific
E70.21 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Hypertyrosinemia
Includes (from E70)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory tyrosinemia of newborn (P74.5) (from E70.2)
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E70)
- androgen insensitivity syndrome (E34.5-) (from E70)
- congenital adrenal hyperplasia (E25.0) (from E70)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E70)
- Marfan syndrome (Q87.4-) (from E70)
- 5-alpha-reductase deficiency (E29.1) (from E70)
Excludes2
Not included here — may be reported together when both conditions exist.
Also known as
- Hypertyrosinemia
- Tyrosinosis
Parent code
- E70.2Disorders of tyrosine metabolismHeader